Advisor Group Holdings, Inc. Ultragenyx Pharmaceutical Inc. Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 327 shares of RARE stock, worth $14,665. This represents 0.0% of its overall portfolio holdings.

Number of Shares

327

Previous 487 32.85%

Holding current value

$14,665

Previous $20,000 10.0%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$40.21 - $59.36 $6,433 - $9,497	-160 Reduced 32.85%	327 $18,000
Q2 2024 Aug 13, 2024	SELL	$37.42 - $51.61 $11,862 - $16,360	-317 Reduced 39.43%	487 $20,000
Q1 2024 May 10, 2024	SELL	$43.02 - $53.69 $173,112 - $216,048	-4,024 Reduced 83.35%	804 $37,000
Q4 2023 Feb 12, 2024	SELL	$31.73 - $49.19 $82,212 - $127,451	-2,591 Reduced 34.92%	4,828 $230,000
Q3 2023 Nov 13, 2023	SELL	$34.92 - $46.66 $5,552 - $7,418	-159 Reduced 2.1%	7,419 $264,000
Q2 2023 Aug 10, 2023	BUY	$37.35 - $52.15 $74,027 - $103,361	1,982 Added 35.42%	7,578 $349,000
Q1 2023 May 12, 2023	BUY	$36.99 - $48.71 $25,449 - $33,512	688 Added 14.02%	5,596 $224,000
Q4 2022 Feb 10, 2023	BUY	$33.72 - $46.33 $34,326 - $47,163	1,018 Added 26.17%	4,908 $227,000
Q3 2022 Nov 14, 2022	BUY	$39.96 - $66.14 $39,960 - $66,140	1,000 Added 34.6%	3,890 $162,000
Q2 2022 Aug 10, 2022	BUY	$45.8 - $85.4 $3,435 - $6,405	75 Added 2.66%	2,890 $171,000
Q1 2022 May 04, 2022	BUY	$62.2 - $84.4 $74,826 - $101,533	1,203 Added 74.63%	2,815 $198,000
Q3 2021 Nov 05, 2021	BUY	$77.92 - $102.4 $26,414 - $34,713	339 Added 26.63%	1,612 $146,000
Q2 2021 Aug 02, 2021	SELL	$92.19 - $115.71 $129,158 - $162,109	-1,401 Reduced 52.39%	1,273 $122,000
Q1 2021 May 13, 2021	BUY	$106.9 - $167.73 $91,078 - $142,905	852 Added 46.76%	2,674 $306,000
Q4 2020 Feb 10, 2021	BUY	$84.4 - $177.39 $20,931 - $43,992	248 Added 15.76%	1,822 $253,000
Q3 2020 Nov 12, 2020	BUY	$72.98 - $90.0 $30,505 - $37,620	418 Added 36.16%	1,574 $128,000
Q2 2020 Aug 14, 2020	BUY	$46.91 - $78.22 $9,241 - $15,409	197 Added 20.54%	1,156 $90,000
Q1 2020 May 18, 2020	BUY	$33.8 - $62.9 $32,414 - $60,321	959 New	959 $43,000

Others Institutions Holding RARE

# of Institutions

325

Shares Held

85.5M

Call Options Held

520K

Put Options Held

406K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.14B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Ultragenyx Pharmaceutical Inc. Transaction History